Amphiphilic nanocarrier-induced modulation of PLK1 and miR-34a leads to improved therapeutic response in pancreatic cancer.
Gibori H, Eliyahu S, Krivitsky A, Ben-Shushan D, Epshtein Y, Tiram G, Blau R, Ofek P, Lee JS, Ruppin E, Landsman L, Barshack I, Golan T, Merquiol E, Blum G, Satchi-Fainaro R.
Gibori H, et al. Among authors: landsman l.
Nat Commun. 2018 Jan 2;9(1):16. doi: 10.1038/s41467-017-02283-9.
Nat Commun. 2018.
PMID: 29295989
Free PMC article.